Cargando…
Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma
PURPOSE: Based on improvements of progression-free survival (PFS), new agents for metastatic renal cell carcinoma (mRCC) have been approved. It is assumed that one of the benefits is a delay in health-related quality of life (HRQoL) deterioration as a result of a delay in progression of disease. How...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770482/ https://www.ncbi.nlm.nih.gov/pubmed/28917029 http://dx.doi.org/10.1007/s11136-017-1704-4 |